c-Myc promotes differentiation of human epidermal stem cells

Genes and Development

Volumn 11, Issue 21, 1997, Pages 2869-2882

  Gandarillas, Alberto ^a   Watt, Fiona M ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

4 Hydroxytamoxifen; Epidermis; Integrins; Involucrin; Keratinocytes

Indexed keywords

4 HYDROXYTAMOXIFEN; INTEGRIN; INVOLUCRIN; MYC PROTEIN;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL RENEWAL; CONTROLLED STUDY; EPIDERMIS CELL; HUMAN; HUMAN CELL; KERATINOCYTE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DOMAIN; STEM CELL; TRANSCRIPTION REGULATION;

EID: 0030778620     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.21.2869     Document Type: Article

References (67)

1. Adams, J.C. and F.M. Watt. 1989. Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature 340: 307-309.
2. Alarcon, R.M., B.A. Rupnow, T.G. Graeber, S.J. Knox, and A.J. Giaccia. 1996. Modulation of c-Myc activity and apoptosis in vivo. Cancer Res. 56: 4315-4319.
3. 1. Proc. Natl. Acad. Sci. 92: 3239-3243.
4. Amati, B. and H. Land. 1994. Myc-Max-Mad: A transcription factor network controlling cell cycle progression, differentiation and death. Curr. Opin. Genet. Dev. 4: 102-108.
5. Askew, D., R.A. Ashmun, B.C. Simmons, and J.L. Cleveland. 1991. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915-1922.
6. Asselineau, D., B.A. Bernard, C. Bailly, and M. Darmon. 1989. Retinoic acid improves epidermal morphogenesis. Dev. Biol. 133: 322-335.
7. Basset-Séguin, N., J.F. Culard, C. Kerai, F. Bernard, A. Watrin, J. Demaille, and J.J. Guilhou. 1990. Reconstituted skin in culture: A simple method with optimal differentiation. Differentiation 44: 232-238.
8. Blackwood, E.M., T.G. Lugo, L. Kretzner, M.W. King, A.J. Street, O.N. Witte, and R.N. Eisenman. 1994. Functional analysis of the AUG- and CUG-initiated forms of the c-Myc protein. Mol. Biol. Cell 5: 597-609.
9. Cañelles M., M.D. Delgado, K.M. Hyland, A. Lerga, C. Richard, C.V. Dang, and J. Léon. 1997. Max and inhibitory c-Myc mutants induce erythroid differentiation and resistance to apoptosis in human myeloid leukemia cells. Oncogene 14: 1315-1327.
10. Chin, L., N. Schreiber-Agus, I. Pellicer, K. Chen, H-W. Lee, M. Dudast, C. Cordon-Cardo, and R.A. DePinho. 1995. Contrasting roles for Myc and Mad proteins in cellular growth and differentiation. Proc. Natl. Acad. Sci. 92: 8488-8492.
11. Cooper, G.M. 1990. Oncogenes. Pub. Jones and Bartlett, Boston. pp. 1-323.
12. Dale, B.A., K.A. Resing, and R.B. Presland. 1994. Keratohyalin granule proteins. In The keratinocyte handbook. (ed. I.M. Leigh, E.B. Lane, and F.M. Watt), pp. 323-350. Cambridge University Press, Cambridge, UK.
13. Dang, C.V., M. McGuire, M. Buckmire, and W.M. Lee. 1989. Involvement of the "leucine zipper" region in the oligomerization and transforming activity of human c-myc protein. Nature 337: 664-666.
14. Danielian, P.S., R. White, S.A. Hoare, S.E. Fawell, and M.G. Parker. 1993. Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol. Endocrinol 7: 232-240.
15. DePinho, R.A., N. Schreiber-Agus, and F.W. Alt. 1991. myc family oncogenes in the development of normal and neoplastic cells. Adv. Cancer Res. 57: 1-46.
16. Dittel, B.N., J.B. McCarthy, E.A. Wayner, and T.W. LeBien. 1993. Regulation of human B-cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1). Blood 81: 2272-2282.
17. Dover, R. and F.M. Watt. 1987. Measurement of the rate of epidermal terminal differentiation: Expression of involucrin by S-phase keratinocytes in culture and in psoriatic plaques. J. Invest. Dermatol. 89: 349-352.
18. Evan, G.I. and T.D. Littlewood. 1993. The role of c-myc in cell growth. Curr. Opin. Genet. Dev. 3: 44-49.
19. Evan, G.I., A.H. Wyllie, C.S. Gilbert, T.D. Littlewood, H. Land, M. Brooks, C.M. Waters, L.Z. Penn, and D.C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128.
20. Evan, G.I., G.K. Lewis, G. Ramsay, and I.M. Bishop. 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell Biol. 5: 3610-3616.
21. Frisch, S.M. and H. Francis. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124: 619-626.
22. Fuchs, E. and C. Bryne. 1994. The epidermis: Rising to the surface. Curr. Opin. Genet. Dev. 4: 725-736.
23. Gandarillas, A. and F.M. Watt. 1995. Changes in expression of members of the fos and jun families and myc network during terminal differentiation of human keratinocytes. Oncogene 11: 1403-1407.
24. Greenhalgh, D.A. and S.H. Yuspa. 1988. Malignant conversion of murine squamous papilloma cell lines by transfection with the fos oncogene. Mol Carcinog. 1: 134-143.
25. Hall, P.A. and F.M. Watt. 1989. Stem cells: The generation and maintenance of cellular diversity. Development 106: 619-633.
26. Hann, S.R., M. Dixit, R.C. Sears, and L. Sealy. 1994. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. Genes & Dev. 8: 2441-2452.
27. Harrington, E.A., A. Fanidi, and G.I. Evan. 1994. Oncogenes and cell death. Curr. Opin. Genet. Dev. 4: 120-129.
28. Hashiro, M., K. Matsumoto, H. Okumura, K. Hashimoto, and K. Yoshikawa. 1991. Growth inhibition of human keratinocytes by antisense c-myc oligomer is not coupled to induction of differentiation. Biochem. Biophys. Res. Comm. 174: 287-292.
29. Henriksson, M. and B. Lüscher. 1996. Proteins of the Myc network: Essential regulators of cell growth and differentiation. Adv. Cancer Res. 68: 109-182.
30. Hudson, D.L., K.L. Weiland, T.P. Dooley, M. Simon, and F.M. Watt. 1992. Characterisation of eight monoclonal antibodies to involucrin. Hybridoma 11: 367-379.
31. Hurlin, P.J., K.P. Foley, D.E. Ayer, R.N. Eisenman, D. Hanahan, and I.M. Arbeit. 1995a. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene 11: 2487-2501.
32. Hurlin, P.J., C. Quéva, P.J. Koskinen, E. Steingrímsson, D.E. Ayer, N.G. Copeland, N.A. Jenkins, and R.N. Eisenman. 1995b. Mad3 and Mad4: Novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 14: 5646-5659.
33. Jones, P.H. and F.M. Watt. 1993. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73: 713-724.
34. Jones, P.H., S. Harper, and F.M. Watt. 1995. Stem cell patterning and fate in human epidermis. Cell 80: 83-93.
35. 1 integrin subunit. Oncogene 11: 2599-2607.
36. _. 1997. Concomitant down-regulation of expression of integrin subunits by N-myc in human neuroblastoma cells: Differential regulation of α2, α3 and β1. Oncogene 14: 1341-1350.
37. Kaufmann, R., D. Frösch, C. Westphal, L. Weber, and C.E. Klein. 1989. Integrin VLA-3: Ultrastructural localization at cell-cell contact sites of human cell cultures. J. Cell Biol. 109: 1807-1815.
38. Kupper, T.S. 1990. The activated keratinocyte: A model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J. Invest. Dermatol. 94: 146S-150S.
39. 4. Nature 227: 680-685.
40. Lee, L.A., C. Dolde, J. Barrett, C.S. Wu, and C.V. Dang. 1996. A link between c-Myc-mediated transcriptional repression and neoplastic transformation. J. Clin. Invest. 97: 1687-1695.
41. Li, L., C. Nerlov, G. Prendergast, D. MacGregor, and E.B. Ziff. 1994. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J. 13: 4070-4079.
42. Littlewood, T.D., B. Amati, H. Land, and G.I. Evan. 1992. Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene 7: 1783-1792.
43. Littlewood, T.D., D.C. Hancock, P.S. Danielian, M.G. Parker, and G.I. Evan. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23: 1686-1690.
44. Lymboussaki, A., A. Kaipainen, E. Hatva, I. Västrik, L. Jeskanen, M. Jalkanen, S. Werner, F. Stanbäck, and R. Alitalo. 1996. Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin. Br. J. Cancer 73: 1347-1355.
45. Markowitz, D., S. Goff, and A. Bank. 1988. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167: 400-406.
46. McKay, I.A. and I.M. Leigh. 1991. Epidermal cytokines and their role in cutaneous wound healing. Br. J. Dermatol. 124: 513-518.
47. McNally, N.J. and G.D. Wilson. 1990. Measurement of tumour cell kinetics by the bromodeoxyuridine method. In Flow cytometry. A practial approach. (ed. M.G. Ormerod), pp. 87-104. IRL Press, Oxford, UK.
48. Morgenbesser, S.D. and R.A. DePinho. 1994. Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. Semin. Cancer Biol 5: 21-36.
49. Morgenstern, J.P. and H. Land. 1991. Choice and manipulation of retroviral vectors. Methods MoL Biol. 7: 181-206.
50. Packham, G. and J.L. Cleveland. 1995. c-Myc and apoptosis. Biochim. Biophys. Acta 1242: 11-28.
51. Pietenpol, I.A., J.T. Holt, R.W. Stein, and H.L. Moses. 1990. Transforming growth factor β1 suppression of c-myc gene transcription: Role in inhibition of keratinocyte proliferation. Proc. Natl. Acad. Sci. 87: 3758-3762.
52. Polakowska, R.R. and A.R. Haake. 1994. Apoptosis: The skin from a new perspective. Cell Death Differ. 1: 19-31.
53. Potten, C.S. and R.J. Morris. 1988. Epithelial stem cells in vivo. J. Cell Sci. (Suppl.) 10: 45-62.
54. Pruniéras, M., M. Réginier, and D. Woodley. 1983. Methods for cultivation of keratinocytes with an air-liquid interface. J. Invest. Dermatol. 81: 28S-33S.
55. Rheinwald, J. G. 1989. Methods for clonal growth and serial cultivation of normal human epidermal keratinocytes and mesothelial cells. In Cell growth and division. A practical approach (ed. R. Baserga), pp. 81-94. IRL Press, Oxford, UK.
56. Rheinwald, J.G. and H. Green. 1975. Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma. Cell 6: 317-330.
57. Rikimaru, K., J-P. Molès, and F.M. Watt. 1997. Correlation between hyperproliferation and suprabasal integrin expression in human epidermis reconstituted in culture. Exp. Dermatol. 6: 214-221.
58. Ruoslahti, E. and J.C. Reed. 1994. Anchorage dependence, integrins, and apoptosis. Cell 77: 477-478.
59. Sawyers, C.L., W. Callahan, and O.N. Witte. 1992. Dominant negative MYC blocks transformation by ABL oncogenes. Cell 70: 901-910.
60. Schlütter, C., M. Duchrow, C. Wohlenberg, M.H.G. Becker, G. Key, H-D. Flad, and J. Gerdes. 1993. The cell proliferation-associated antigen of antibody Ki-67: A very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J. Cell Biol. 123: 513-522.
61. Spotts, G.D., S.V. Patel, Q. Xiao, and S.R. Hann. 1997. Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol. Cell. Biol. 17: 1459-1468.
62. Toftgard, R., D.R. Roop, and S.H. Yuspa. 1985. Proto-oncogene expression during two-stage carcinogenesis in mouse skin. Carcinogenesis 6: 655-657.
63. Västrik, I., A. Kaipainen, T-L. Penttilä, A. Lymboussakis, R. Alitalo, M. Parvinen, and K. Alitalo. 1995. Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J. Cell Biol. 128: 1197-1208.
64. Watt, F.M. 1989. Terminal differentiation of epidermal keratinocytes. Curr. Opin. Cell Biol. 1: 1107-1115.
65. _. 1994. Cultivation of human epidermal keratinocytes with a 3T3 feeder layer. In Cell biology: A laboratory handbook (ed. J.E. Celis), pp. 83-89. Cambridge University Press, Cambridge, UK.
66. Yaar, M., A. Gilani, P.J. DiBenedetto, D.D. Harkness, and B.A. Gilchrest. 1993. Gene modulation accompanying differentiation of normal versus malignant keratinocytes. Exp. Cell Res. 206: 235-243.
67. Younus, J. and B.A. Gilchrest. 1992. Modulation of mRNA levels during human keratinocyte differentiation. J. Cell Physiol. 152: 232-239.